FUKOKU MUTUAL LIFE INSURANCE Co Has $474,000 Holdings in Danaher Corporation $DHR

FUKOKU MUTUAL LIFE INSURANCE Co decreased its position in Danaher Corporation (NYSE:DHR) by 14.6% in the second quarter, HoldingsChannel reports. The firm owned 2,402 shares of the conglomerate’s stock after selling 411 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Danaher were worth $474,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Red Tortoise LLC lifted its holdings in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Ramirez Asset Management Inc. acquired a new position in Danaher during the second quarter valued at $40,000. Costello Asset Management INC purchased a new stake in Danaher in the 1st quarter worth about $41,000. Strengthening Families & Communities LLC lifted its stake in Danaher by 81.4% in the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after acquiring an additional 114 shares in the last quarter. Finally, Saudi Central Bank acquired a new stake in Danaher during the 1st quarter worth about $52,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR stock opened at $222.58 on Thursday. The firm has a 50 day moving average of $207.29 and a two-hundred day moving average of $201.61. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a market capitalization of $157.22 billion, a price-to-earnings ratio of 45.89, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.71 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on DHR shares. Robert W. Baird set a $247.00 price target on shares of Danaher in a research report on Wednesday, October 22nd. TD Cowen upped their price objective on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Guggenheim reiterated a “buy” rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Rothschild Redb cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Finally, Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president owned 2,625 shares in the company, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 33,026 shares of company stock worth $7,195,987. 11.10% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.